SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-11-003438
Filing Date
2011-01-27
Accepted
2011-01-27 16:41:36
Documents
4
Period of Report
2011-01-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a11-4674_18k.htm 8-K 31261
2 EX-10.1 a11-4674_1ex10d1.htm EX-10.1 53671
3 GRAPHIC g46741kai001.jpg GRAPHIC 63858
4 GRAPHIC g46741kai002.gif GRAPHIC 55410
  Complete submission text file 0001104659-11-003438.txt   251201
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 11552661
SIC: 2836 Biological Products, (No Diagnostic Substances)